Cargando…
Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent
Recently, new therapeutics have been developed for hepatocellular carcinoma (HCC). However, the overall survival rate of HCC patients is still unsatisfactory; one of the reasons for this is the high frequency of recurrence after radical treatment. Consequently, to improve prognosis, it will be impor...
Autores principales: | Enjoji, Munechika, Watase, Daisuke, Matsunaga, Kazuhisa, Kusuda, Mariko, Nagata-Akaho, Nami, Karube, Yoshiharu, Takata, Jiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548248/ https://www.ncbi.nlm.nih.gov/pubmed/28943616 http://dx.doi.org/10.3390/diseases3030150 |
Ejemplares similares
-
Antitumor Effects and Delivery Profiles of Menahydroquinone-4 Prodrugs with Ionic or Nonionic Promoiety to Hepatocellular Carcinoma Cells
por: Setoguchi, Shuichi, et al.
Publicado: (2018) -
Prodrugs for Skin Delivery of Menahydroquinone-4, an Active Form of Vitamin K(2(20)), Could Overcome the Photoinstability and Phototoxicity of Vitamin K(2(20))
por: Goto, Shotaro, et al.
Publicado: (2019) -
Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K(2(20)), on All-Trans Retinoic Acid-Resistant HL60 Cell Line
por: Yamakawa, Hirofumi, et al.
Publicado: (2021) -
Novel Cationic Prodrug of Ubiquinol-10 Enhances Intestinal Absorption via Efficient Formation of Nanosized Mixed-Micelles with Bile Acid Anions
por: Setoguchi, Shuichi, et al.
Publicado: (2020) -
Cationic N,N-Dimethylglycine Ester Prodrug of 2R-α-Tocotrienol Promotes Intestinal Absorption via Efficient Self-Micellization with Intrinsic Bile Acid Anion
por: Watase, Daisuke, et al.
Publicado: (2022)